Current clinical perspectives and implications of cirrhotic ascites in China
-
摘要:
近年国内对肝硬化腹水发病机制、诊断、治疗有较多研究,与既往相比出现了较大差距,突出问题:(1)根据钠潴留机制限钠、利尿治疗不仅未能抑制肾素-血管紧张素-醛固酮系统(RAAS)活性,反而限钠越严格,RAAS活性就越强。纠正低血钠后RAAS活性受到抑制;(2)肝硬化腹水患者并非因血管活性物质紊乱导致血容量不足而诱发肝肾综合征(HRS),而是限钠、利尿导致血容量不足诱发HRS;(3)国外(美国)肝硬化腹水诊治指南部分条款相互间出现矛盾。根据这些突出问题,应重视对肝硬化腹水的研究。
-
关键词:
- 肝硬化 /
- 腹水 /
- 肾素-血管紧张素系统 /
- 膳食,限钠
Abstract:In recent years, domestic research efforts have significantly advanced our understanding of the pathogenesis of cirrhotic ascites and led to development of new and improved methods of diagnosis and treatment.Unfortunately, the studies have produced underlying mechanisms remain unknown systematic studies to compare the new and traditional methods are lacking.There is an urgent need to address the following topics and related issues: (1) The mechanism of sodium retention: Sodium restriction treatment regimens and diuretic therapy have not only failed to inhibit activity of the kidney-angiotensin-aldosterone system (RAAS) , but stricter salt restriction has produced stronger RAAS activity.However, correcting hyponatremia effectively inhibited the RAAS activity. (2) The causes and effects of hepatorenal syndrome (HRS) : The established theory that cirrhotic ascites result from disorders of vasoactive substances leading to hypovolemia and subsequent HRS was not shown in patients.However, cirrhosis ascites were shown to be associated with sodium restriction and diuretic status, which is newly theorized to lead to the hypovolemia-induced HRS. (3) Inconsistencies in established management guidelines: Some rules of the USA guidelines for therapy of cirrhotic ascites lack a theoretical basis, resulting in contradictions in diagnosis and treatment, which may also be explained by ethnic-specific features.Thus, it is necessary to formulate a new set of guidelines for diagnosis and treatment of cirrhotic ascites in Chinese patients based on a comprehensive understanding of the underlying molecular and biological pathogenic mechanisms.
-
Key words:
- liver cirrhosis /
- ascites /
- renin-angiotensin system /
- diet
-
[1]刘建军.如何理解肝硬化腹水限钠与补钠问题[J].临床肝胆病杂志, 2009, 25 (3) :163-166. [2]顾锡炳, 陈浩坤, 朱银芳, 等.补钠与限钠对肝硬化肾素-血管紧张素-醛固酮及肾功能的影响[J].中华肝脏病杂志, 2004, 12 (6) :370-371. [3]刘建军, 吴晓英.对肝肾综合征几个问题的重新评价[J].肝脏, 2004, 9 (1) :42-43. [4]刘建军, 吴晓英.重新认识与评价肝硬化腹水的几个问题[J].中华消化杂志, 2007, 27 (5) :330-331. [5]曾欣, 林勇, 谢渭芬.关于肝硬化腹水治疗中限钠之我见[J].中华消化杂志, 2007, 27 (5) :331-333. [6]刘建军, 吴晓英, 智红, 等.肝硬化腹水患者限钠治疗诱发低渗性脑病临床分析[J].胃肠病学与肝脏病学杂志, 1998, 7 (3) :178-180. [7] 王宁, 贾继东.肝肾综合征的治疗[J].临床肝胆病杂志, 2008, 2 (1) :12-15. [8]刘建军, 智红, 闫晓英.对2009年《美国成人肝硬化腹水诊治指南》的几点评价[J].中西医结合肝病杂志, 2010, 20 (4) :251-252.
计量
- 文章访问数: 2262
- HTML全文浏览量: 7
- PDF下载量: 700
- 被引次数: 0